Incorporating the 40-Gene Expression Profile (40-GEP) Test Within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed With Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors. J of Skin 2024, 8 (1), s334. https://doi.org/10.25251/skin.8.supp.334.